Microfibril Collagen Hemostat is a medical product that is used as a hemostatic agent to control bleeding during surgical procedures or in cases of traumatic injuries. It is composed of microfibrillar collagen, which consists of small strands or threads of natural collagen protein derived from animal sources, such as bovine or porcine tissue.
Microfibril Collagen Hemostat promotes hemostasis by interacting with the blood components and initiating the clotting process. When applied to a bleeding site, it quickly absorbs the surrounding fluids, including blood, and transforms into a gelatinous mass, which aids in the formation of a blood clot. The microfibrillar structure enhances the clotting mechanism by increasing the surface area for platelet adhesion and aggregation, therefore, accelerating the clot formation.
This hemostatic agent is typically available in various forms, including sheets, sponges, powders, or granules, which can be easily applied to the bleeding wound or surgical site. It is widely used in a variety of surgical specialties, such as general surgery, orthopedics, neurosurgery, and cardiovascular surgery, as it assists in achieving rapid and effective control of bleeding.
Microfibril Collagen Hemostat is biocompatible and biodegradable, meaning that it is safely absorbed and eliminated by the body over time without causing any adverse reactions or complications. However, it is important to follow proper medical guidelines and instructions for usage to ensure optimal outcomes and minimize any potential risks associated with its application.
